Correlation between Onset of Renal Disease with Diabetes: onset of renal disease in diabetics

Misbah  Arshad; Mamoona  Ashfaq; Zargham  Mazhar; Zainab  Sharmeen

doi:10.52229/pbmj.v2i2.18

Authors

Misbah Arshad University Institute of Diet and Nutritional Sciences, Faculty of Allied Health Sciences, The University of Lahore, Lahore, Pakistan
Mamoona Ashfaq University Institute of Diet and Nutritional Sciences, Faculty of Allied Health Sciences, The University of Lahore, Lahore, Pakistan
Zargham Mazhar University Institute of Diet and Nutritional Sciences, Faculty of Allied Health Sciences, The University of Lahore, Lahore, Pakistan
Zainab Sharmeen University Institute of Diet and Nutritional Sciences, Faculty of Allied Health Sciences, The University of Lahore, Lahore, Pakistan

DOI:

https://doi.org/10.52229/pbmj.v2i2.18

Abstract

Diabetes is associated with number of vascular and nonvascular complications, and the vascular complications which include Cardiovascular Disease (CVD), peripheral vascular disease (PVD), stroke, retinopathy, neuropathy, and Diabetic Kidney Diseases (DKD are responsible for most of the morbidity and mortality attributable to diabetes. Objective: The aim of this study was to determine the correlation of onset of any renal disease with diabetes in Pakistani population. Methods: A cross sectional study was conducted at Medicine and Nephrology Departments of the Sir Ganga Ram Hospital, Lahore, over a period of 3 months, after obtaining the ethical approval from the The University of Lahore. A total number of 100 Diabetic patients were selected through non probability convenient sampling technique. Patients of both sexes and all age groups were included. Results: In this study 60% were male and 40% were female. Most of the patients belonged to lower socioeconomic status. Frequency of onset of diabetes with age showed that patients between age of 41-50 years (33%) were more susceptible to diabetes and its complications whereas onset of diabetes was relatively higher in males as compared to females. Frequency distribution of CVD among diabetic patients was 19%. Conclusions: Results of current findings showed that diabetes mellitus also leads toward further microvascular complications and co-exist with different diseases.

References

Fagerudd JA, Pettersson-Fernholm KJ, Grönhagen-Riska C, Groop PH. (1999). The impact of a family history of Type II (non-insulin-dependent) diabetes mellitus on the risk of diabetic nephropathy in patients with Type I (insulin-dependent) diabetes mellitus. Diabetologia, 42(5): 519-526.

Janssen B, Hohenadel D, Brinkkoetter P, Peters V, Rind N, Fischer C, Rychlik I, Cerna M, Romzova M, de Heer E, Baelde H. (2005). Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1. Diabetes, 54(8): 2320-2327.

Geraldes P, King GL. (2010). Activation of protein kinase C isoforms and its impact on diabetic complications. Circulation research, 106(8): 1319-1331.

Volpato S, Blaum C, Resnick H, Ferrucci L, Fried LP, Guralnik JM. (2002). Comorbidities and impairments explaining the association between diabetes and lower extremity disability: The Women’s Health and Aging Study. Diabetes Care, 25(4): 678-683.

Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, Chen SJ, Dekker JM, Fletcher A, Grauslund J, Haffner S. (2012). Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care, 35(3): 556-564.

Elman MJ, Aiello LP, Beck RW, Bressler NM, Bressler SB, Edwards AR, Ferris III FL, Friedman SM, Glassman AR, Miller KM, Scott IU. (2010). Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology, 117(6): 1064-1077.

Somaa BO, Almgren P, Tuomi T, Forsén B, Lahti K, Nissen M, Taskinen MR, Groop L. (2001). Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 24(4): 683-689.

Grant PJ. (2007). Diabetes mellitus as a prothrombotic condition. Journal of Internal Medicine, 262(2):157-172.

Levey AS, Coresh J, Bolton K, Culleton B, Harvey KS, Ikizler TA, Johnson CA, Kausz A, Kimmel PL, Kusek J, Levin A. (2002). K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. American Journal of Kidney Diseases, 39(2 SUPPL. 1).

Adler S. (2004). Diabetic nephropathy: Linking histology, cell biology, and genetics. Kidney International, 66(5): 2095-2106.

McKenna MT, Michaud CM, Murray CJ, Marks JS. McKenna, M. T., Michaud, C. M., Murray, C. J., & Marks, J. S. (2005). Assessing the burden of disease in the United States using disability-adjusted life years. American Journal of Preventive Medicine, 28(5): 415-423.

Huxley R, Barzi F, Woodward M (2006). Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ, 12: 332(7533):73-8.

Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P. (2003). Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation, 108(17): 2154-2169.

Dirks JH, De Zeeuw D, Agarwal SK, Atkins RC, Correa-Rotter R, D'Amico G, Bennett PH, El Nahas M, Valdes RH, Kaseje DA, Katz IJ. (2005). Prevention of chronic kidney and vascular disease: Toward global health equity—The Bellagio 2004 Declaration. Kidney International, 68: S1-S6.

Lysaght MJ. (2002). Maintenance dialysis population dynamics: current trends and long-term implications. Journal of the American Society of Nephrology, 13(suppl 1): S37-S40.

Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR. (2003). Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney International, 63(1): 225-232.

Valmadrid CT, Klein R, Moss SE, Klein BE. (2000). The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Archives of internal medicine, 160(8): 1093-1100.

Yeung RO, Zhang Y, Luk A, Yang W, Sobrepena L, Yoon KH, Aravind SR, Sheu W, Nguyen TK, Ozaki R, Deerochanawong C. (2014). Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort. The lancet Diabetes & endocrinology, 2(12): 935-943.

Harita N, Hayashi T, Sato KK, Nakamura Y, Yoneda T, Endo G, Kambe H. (2009). Lower serum creatinine is a new risk factor of type 2 diabetes: the Kansai healthcare study. Diabetes care, 32(3): 424-426.

Jadoon NA, Shahzad MA, Yaqoob R, Hussain M, Ali N. (2010). Seroprevalence of hepatitis C in type 2 diabetes: evidence for a positive association. Virology Journal, 7(1): 304.

Ruggenenti P, Fassi A, Ilieva AP, Bruno S, Iliev IP, Brusegan V, Rubis N, Gherardi G, Arnoldi F, Ganeva M, Ene-Iordache B. (2004). Preventing microalbuminuria in type 2 diabetes. New England Journal of Medicine, 351(19): 1941-1951.